Report cover image

Injectable Drugs Market

Publisher Future Market Insights
Published Jun 24, 2022
Length 341 Pages
SKU # FMARI17949511

Description

Injectable Drugs Market


Injectable Drugs Market: Global Industry Analysis 2014-2021 and Opportunity Assessment 2022-2032
A recent market study published by FMI on Injectable Drugs Market offers a global industry analysis for 2014-2021 and opportunity assessment for 2022-2032. The study offers a comprehensive assessment of the most important market dynamics. After conducting thorough research on the historical and current growth parameters, the growth prospects of the market are obtained with maximum precision.
Market Segmentation
The global Injectable Drugs Market is segmented in detail to cover every aspect of the market and present complete market intelligence to readers.
By Product: • Monoclonal Antibodies
• Immunoglobulin
• Cytokines
• Insulin
• Peptide Hormones
• Blood Factors
• Peptide Antibiotics
• Vaccines
• Small Molecule Antibiotics
• Chemotherapy Agents
• Others
By Application: • Oncology
• Infectious Diseases
• Diabetes
• Blood disorders
• Hormonal Disorders
• Musculoskeletal Disorders
• CNS Diseases
• Pain Management
• Cardiovascular Diseases
By Molecule Type: • Small Molecules
• Large Molecules
By Route of Administration: • Intravenous (IV)
• Intramuscular (IM)
• Subcutaneous (SC)
By Distribution Channel: • Hospital Pharmacies
• Retail Pharmacies
• Drug Stores
• Online Pharmacies
By Region: • North America
• Latin America
• Europe
• East Asia
• South Asia
• Oceania
• The Middle East and Africa (MEA)
Report Chapters
Executive Summary
The executive summary of the Injectable Drugs Market includes the global market outlook, demand side trends, supply side trends and also include FMI analysis and recommendations of Crowdsourced Security.
Chapter 01 – Market Overview
Readers can find the detailed segmentation and definition of the Injectable Drugs Market in this chapter, which will help to understand basic information about crowdsourced security. This section also highlights the market scope, taxonomy and limitations which help the reader understand the market coverage of Injectable Drugs Market report.
Chapter 02 – Market Background
This chapter includes detailed analysis of the product processing methods overview, consumer buying patterns & tendencies and policy developments and regulatory scenario. It also includes in depth analysis of macro-economic factors and covers topics like global GDP growth outlook, global industry value added, personal consumption, expenditures, modern trade penetration and consumer price indices. The chapter also covers forecast factors - relevance & impact, value chain analysis and market dynamics (drivers, restraints and opportunities) to better understand the market.
Chapter 03 – Global Injectable Drugs Market Demand Analysis 2014-2021 and Forecast, 2022-2032
The chapter include historical market value (USD XX Mn) analysis (2015-2021) and current and future market value (US$ 531.8 Bn) and volume (5.8%) projections (2022-2032). The projections are based on the Y-O-Y growth trend analysis and absolute $ opportunity analysis country of operation.
Chapter 04 – Global Injectable Drugs Market - Pricing Analysis
Based on By Type, the pricing analysis chapter include regional pricing analysis (USD/MT), global average pricing analysis benchmark, and key factors impacting the pricing.
Chapter 05 – Global Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032, By Product
Based on By Product, Injectable Drugs Market is segmented into Monoclonal Antibodies, Immunoglobulin, Cytokines, Insulin, Peptide Hormones, Blood Factors, Peptide Antibiotics, Vaccines, Small Molecule Antibiotics, Chemotherapy Agents. This section also offers market attractiveness analysis based on By Product. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Product
Chapter 06 – Global Injectable Drugs Market Analysis 2018-2022 and Forecast 2023-2033, By Application
Based on By Application, Injectable Drugs Market is segmented into Oncology, Infectious Diseases, Diabetes, Blood disorders, Hormonal Disorders, Musculoskeletal Disorders, CNS Diseases, Pain Management, Cardiovascular Diseases. This section also offers market attractiveness analysis based on By Application. Value forecast and Y-o-Y growth comparison will also be provided for above mentioned By Application.
Chapter 06 – Global Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032, By Region
Based on region, Injectable Drugs Market report covers North America, Latin America, Europe, East Asia, South Asia, Oceania, The Middle East and Africa (MEA). This section also offers market attractiveness analysis based on region. Readers can also find value forecast and Y-o-Y growth comparison for all above mentioned regions.
Chapter 7 – North America Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of the Injectable Drugs Market in the North American region, along with a country-wise assessment that includes the US and Canada. Readers can also find regional trends, regulations, and market growth based on different segment and countries in the North America region.
Chapter 8 – Latin America Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Injectable Drugs Market in the Latin America region, along with a country-wise assessment that includes the Brazil, Mexico, Chile, Argentina, Peru and Rest of Latin America. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Injectable Drugs Market in the Latin America region.
Chapter 9 – Europe Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Injectable Drugs Market in the European region, along with a country-wise assessment that includes the Germany, Italy, France, U.K., Spain, Russia, Nordic, Benelux and Rest of Europe. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Injectable Drugs Market in the regional market.
Chapter 13 – East Asia Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Injectable Drugs Market in the East Asia region, along with a country-wise assessment that includes the China, Japan, and South Korea. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Injectable Drugs Market in the regional market.
Chapter 14 – South Asia Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Injectable Drugs Market in the South Asia region, along with a country-wise assessment that includes the India, Indonesia, Malaysia, Thailand, and Rest of South Asia. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Injectable Drugs Market in the regional market.
Chapter 15 - Middle East and Africa Injectable Drugs Market Analysis 2014-2021 and Forecast 2022-2032
This chapter includes a detailed analysis of the growth of Injectable Drugs Market in the MEA region, along with a country-wise assessment that includes the GCC Countries, South Africa, North Africa, Turkey and Rest of MEA. Readers can find detailed information about several factors, such as the pricing analysis and regional trends, which are impacting growth of the Injectable Drugs Market in the regional market.
Chapter 16 - Key Countries Injectable Drugs Market Analysis 2015–2021 and Forecast 2022–2032
This chapter offers insights into how the Injectable Drugs Market is expected to grow in major countries globally.
Chapter 17 - Market Structure Analysis- Global Assessment
This chapter includes company dashboard, industry structure analysis by tier of companies, 2022E, company share analysis of top players, 2022E, and competition benchmarking- matrix.
Chapter 18 - Competition Deep Dive (Tentative List)
This chapter includes company overview, product portfolio of companies, profitability by market segments, sales footprint, SWOT analysis and strategy overview of the companies being studied in the report. Some of the market players featured in the report are Pfizer Inc., Teva Pharmaceutical Industries Ltd., Sanofi S.A., Sun Pharmaceutical Industries Ltd., AstraZeneca Plc, Merck & Co., Inc., Viatris + Mylan N.V, Cipla Inc., Dr Reddy’s Laboratories Ltd., Samsung Biologics, Abbott Laboratories, Amgen Incorporated, Baxter International Incorporated, Becton Dickinson and Company, Bristol-Myers Squibb Company, GlaxoSmithKline Plc, Roche Holding Limited
Chapter 19 - Assumptions and Acronyms
This chapter includes a list of acronyms and assumptions that provide a base to the information and statistics included in the Injectable Drugs Market report.
Chapter 20 – Research Methodology
This chapter helps readers understand the research methodology followed to obtain various conclusions, as well as important qualitative and quantitative information, on Injectable Drugs Market .

Table of Contents

341 Pages
1. Global Market - Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supple Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Definition and Introduction
2.2. Market Taxonomy/ Research Scope
2.3. Inclusions & Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Key Success Factors
4.1. Disease Epidemiology
4.2. Pipeline Analysis
4.3. Regulatory Scenario
4.4. Promotional Strategies, By Key Manufacturers
4.5. Supply chain Analysis
4.6. PESTEL Analysis
4.7. PORTER Analysis
4.8. Number of Clinical Trial
4.9. List of Manufacturers
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Rising per-Capita Healthcare Expenditure
5.1.3. Generic Versions Intensify Total Sale
5.1.4. Plant Upgrades Pushing Pricing of Injectable Drugs
5.1.5. Favorable Reimbursement Scenario Fuels the Market Growth
5.2. Forecast Factors - Relevance & Impact
5.2.1. Product Cost
5.2.2. Frequency of Product Lunches 
5.2.3. Per Patient Spending
5.2.4. Product Awareness
5.2.5. Products in Pipeline 
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID19 Crisis Analysis
6.1. Current COVID19 Statistics and Probable Future Impact
6.2. Current GDP Projection and Probable Impact
6.3. Current Economic Projection as compared to 2008 financial analysis
6.4. COVID19 and Impact Analysis
6.4.1. Revenue By Product
6.4.2. Revenue By Application
6.4.3. Revenue By Molecule
6.4.4. Revenue By Route of Administration
6.4.5. Revenue By Distribution Channel
6.5. 2020 Market Scenario
7. Global Market Value (US$ Bn) Analysis 2014-2021 and Forecast, 2022-2032
7.1. Historical Market Value (US$ Bn) Analysis, 2014-2021
7.2. Current and Future Market Value (US$ Bn) Projections, 2022-2032
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Product 
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Bn) Analysis By Product , 2014-2021
8.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Product, 2022-2032
8.3.1. Monoclonal Antibodies
8.3.2. Immunoglobulin
8.3.3. Cytokines
8.3.4. Insulin
8.3.5. Peptide Hormones
8.3.6. Blood Factors
8.3.7. Peptide Antibiotics
8.3.8. Vaccines
8.3.9. Small Molecule Antibiotics
8.3.10. Chemotherapy Agents
8.3.11. Others
8.4. Market Attractiveness Analysis By Product 
9. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Application  
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Bn) Analysis By Application , 2014-2021
9.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Application , 2022-2032
9.3.1.1. Oncology
9.3.1.2. Infectious Diseases
9.3.1.3. Diabetes
9.3.1.4. Blood disorders
9.3.1.5. Hormonal Disorders
9.3.1.6. Musculoskeletal Disorders
9.3.1.7. CNS Diseases
9.3.1.8. Pain Management
9.3.1.9. Cardiovascular Diseases
9.4. Market Attractiveness Analysis By Application 
10. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Molecule Type 
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) Analysis By Molecule Type, 2014-2021
10.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Molecule Type, 2022-2032
10.3.1.1. Small Molecule
10.3.1.2. Large Molecule
10.4. Market Attractiveness Analysis By Distribution Channel
11. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Route of Administration 
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis By Route of Administration, 2014-2021
11.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Route of Administration, 2022-2032
11.3.1.1. Intravenous
11.3.1.2. Intramuscular
11.3.1.3. Subcutaneous 
11.4. Market Attractiveness Analysis By Route of Administration
12. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Distribution Channel 
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Bn) Analysis By Distribution Channel, 2014-2021
12.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Distribution Channel, 2022-2032
12.3.1.1. Hospital Pharmacies
12.3.1.2. Retail Pharmacies
12.3.1.3. Drug Stores
12.3.1.4. Online Pharmacies
12.4. Market Attractiveness Analysis By Distribution Channel
13. Global Market Analysis 2014-2021 and Forecast 2022-2032, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Bn) Analysis By Region, 2014-2021
13.3. Current and Future Market Size (US$ Bn) Analysis Forecast By Region, 2022-2032
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. South Asia
13.3.5. East Asia
13.3.6. Oceania
13.3.7. Middle East & Africa 
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2014-2021 and Forecast 2022-2032
14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021
14.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
14.3.1. By Country
14.3.1.1. US
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Application
14.3.4. By Molecule Type
14.3.5. Route of administration
14.3.6. By Distribution Channel
14.4. Market Attractiveness Analysis
14.4.1. By Product
14.4.2. By Application
14.4.3. By Molecule Type
14.4.4. Route of administration
14.4.5. By Distribution Channel
14.5. Key Market Participants - Intensity Mapping
14.6. Drivers and Restraints - Impact Analysis
14.7. Country Level Analysis & Forecast
14.7.1. U.S. Market 
14.7.1.1. Introduction
14.7.1.2. Market Analysis and Forecast by Market Taxonomy
14.7.1.2.1. By Product
14.7.1.2.2. By Application
14.7.1.2.3. By Molecule Type
14.7.1.2.4. Route of administration
14.7.1.2.5. By Distribution Channel
14.7.2. Canada Market 
14.7.2.1. Introduction
14.7.2.2. Market Analysis and Forecast by Market Taxonomy
14.7.2.2.1. By Product
14.7.2.2.2. By Application
14.7.2.2.3. By Molecule Type
14.7.2.2.4. Route of administration
14.7.2.2.5. By Distribution Channel
15. Latin America Market Analysis 2014-2021 and Forecast 2022-2032
15.1. Introduction
15.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021
15.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
15.3.1. By Country
15.3.1.1. Brazil
15.3.1.2. Mexico
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Application
15.3.4. By Molecule Type
15.3.5. Route of administration
15.3.6. By Distribution Channel
15.4. Market Attractiveness Analysis
15.4.1. By Product
15.4.2. By Application
15.4.3. By Molecule Type
15.4.4. Route of administration
15.4.5. By Distribution Channel
15.5. Key Market Participants - Intensity Mapping
15.6. Drivers and Restraints - Impact Analysis
15.7. Country Level Analysis & Forecast
15.7.1. Brazil Market 
15.7.1.1. Introduction
15.7.1.2. Market Analysis and Forecast by Market Taxonomy
15.7.1.2.1. By Product
15.7.1.2.2. By D By Application
15.7.1.2.3. By Molecule Type
15.7.1.2.4. Route of administration distribution Channel
15.7.2. Argentina Market
15.7.2.1. Introduction
15.7.2.2. Market Analysis and Forecast by Market Taxonomy
15.7.2.2.1. By Product
15.7.2.2.2. By Application
15.7.2.2.3. By Molecule Type
15.7.2.2.4. Route of administration
15.7.2.2.5. Distribution Channel
15.7.3. Mexico Market 
15.7.3.1. Introduction
15.7.3.2. Market Analysis and Forecast by Market Taxonomy
15.7.3.2.1. By Product
15.7.3.2.2. B By Application
15.7.3.2.3. By Molecule Type
15.7.3.2.4. Route of administration
15.7.3.2.5. Distribution Channel
16. Europe Market Analysis 2014-2021 and Forecast 2022-2032
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021
16.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.1.8.1. By Product 
16.3.1.8.2. By Application
16.3.1.8.3. By Molecule Type
16.3.1.8.4. Route of administration
16.3.1.8.5. By Distribution Channel
16.4. Market Attractiveness Analysis
16.4.1. By Product 
16.4.2. By Application
16.4.3. By Molecule Type
16.4.4. Route of administration
16.4.5. By Distribution Channel
16.5. Country Level Analysis & Forecast
16.5.1. Germany Market
16.5.1.1. Introduction
16.5.1.2. Market Analysis and Forecast by Market Taxonomy
16.5.1.2.1. By Product 
16.5.1.2.2. By Application
16.5.1.2.3. By Molecule Type
16.5.1.2.4. Route of administration
16.5.1.2.5. By Distribution Channel
16.5.2. Italy Market 
16.5.2.1. Introduction
16.5.2.2. Market Analysis and Forecast by Market Taxonomy
16.5.2.2.1. By Product 
16.5.2.2.2. By Application
16.5.2.2.3. By Molecule Type
16.5.2.2.4. Route of administration
16.5.2.2.5. By Distribution Channel
16.5.3. France Market
16.5.3.1. Introduction
16.5.3.2. Market Analysis and Forecast by Market Taxonomy
16.5.3.2.1. By Product 
16.5.3.2.2. By Application
16.5.3.2.3. By Molecule Type
16.5.3.2.4. Route of administration
16.5.3.2.5. By Distribution Channel
16.5.4. U.K.  Injectable Drugs Market
16.5.4.1. Introduction
16.5.4.2. Market Analysis and Forecast by Market Taxonomy
16.5.4.2.1. By Product  
16.5.4.2.2. By Application
16.5.4.2.3. By Molecule Type
16.5.4.2.4. Route of administration
16.5.4.2.5. By Distribution Channel
16.5.5. Spain Market
16.5.5.1. Introduction
16.5.5.2. Market Analysis and Forecast by Market Taxonomy
16.5.5.3. By Product 
16.5.5.4. By Application
16.5.5.5. By Molecule Type
16.5.5.6. Route of administration
16.5.5.7. By Distribution Channel
16.5.6. BENELUX Market
16.5.6.1. Introduction
16.5.6.2. Market Analysis and Forecast by Market Taxonomy
16.5.6.2.1. By Product 
16.5.6.2.2. By Application
16.5.6.2.3. By Molecule Type
16.5.6.2.4. Route of administration
16.5.6.2.5. By Distribution Channel
16.5.7. Russia Market
16.5.7.1. Introduction
16.5.7.2. Market Analysis and Forecast by Market Taxonomy
16.5.7.2.1. By Product 
16.5.7.2.2. By Application
16.5.7.2.3. By Molecule Type
16.5.7.2.4. Route of administration
16.5.7.2.5. By Distribution Channel
17. South Asia Market Analysis 2014-2021 and Forecast 2022-2032
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021
17.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
17.3.1. By Country
17.3.1.1. India
17.3.1.2. Thailand
17.3.1.3. Malaysia
17.3.1.4. Rest Of South Asia
17.3.1.4.1. By Product 
17.3.1.4.2. By Application
17.3.1.4.3. By Molecule Type
17.3.1.4.4. Route of administration
17.3.1.4.5. By Distribution Channel
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product 
17.4.3. By Application
17.4.4. By Molecule Type
17.4.5. Route of administration
17.4.6. By Distribution Channel
17.5. Country Level Analysis & Forecast
17.5.1. India Market
17.5.1.1. Introduction
17.5.1.2. Market Analysis and Forecast by Market Taxonomy
17.5.1.2.1. By Product
17.5.1.2.2. By Application
17.5.1.2.3. By Molecule Type
17.5.1.2.4. Route of administration
17.5.1.2.5. By Distribution Channel
17.5.2. Thailand Market
17.5.2.1. Introduction
17.5.2.2. Market Analysis and Forecast by Market Taxonomy
17.5.2.2.1. By Product 
17.5.2.2.2. By Application
17.5.2.2.3. By Molecule Type
17.5.2.2.4. Route of administration
17.5.2.2.5. By Distribution Channel
17.5.3. Malaysia Market
17.5.3.1. Introduction
17.5.3.2. Market Analysis and Forecast by Market Taxonomy
17.5.3.2.1. By Product 
17.5.3.2.2. By Application
17.5.3.2.3. By Molecule Type
17.5.3.2.4. Route of administration
17.5.3.2.5. By Distribution Channel
18. East Asia Market Analysis 2014-2021 and Forecast 2022-2032
18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend Analysis By Market Taxonomy, 2014-2021
18.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
18.3.1. By Country
18.3.1.1. China
18.3.1.2. Japan
18.3.1.3. South Korea
18.3.1.3.1. By Product 
18.3.1.3.2. By Application
18.3.1.3.3. By Molecule Type
18.3.1.3.4. Route of administration
18.3.1.3.5. By Distribution Channel
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product 
18.4.3. By Application
18.4.4. By Molecule Type
18.4.5. Route of administration
18.4.6. By Distribution Channel
18.5. Country Level Analysis & Forecast
18.5.1. China Market
18.5.1.1. Introduction
18.5.1.2. Market Analysis and Forecast by Market Taxonomy
18.5.1.2.1. By Product 
18.5.1.2.2. By Application
18.5.1.2.3. By Molecule Type
18.5.1.2.4. Route of administration
18.5.1.2.5. By Distribution Channel
18.5.2. Japan Market
18.5.2.1. Introduction
18.5.2.2. Market Analysis and Forecast by Market Taxonomy
18.5.2.2.1. By Product 
18.5.2.2.2. By Application
18.5.2.2.3. By Molecule Type
18.5.2.2.4. Route of administration
18.5.2.2.5. By Distribution Channel
18.5.3. South Korea Market
18.5.3.1. Introduction
18.5.3.2. Market Analysis and Forecast by Market Taxonomy
18.5.3.2.1. By Product 
18.5.3.2.2. By Application
18.5.3.2.3. By Molecule Type
18.5.3.2.4. Route of administration
18.5.3.2.5. By Distribution Channel
19. Oceania Market Analysis 2014-2021 and Forecast 2022-2032
19.1. Introduction
19.2. Historical Market Size (US$ Bn)  and Trend Analysis By Market Taxonomy, 2014-2021
19.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.1.2.1. By Product 
19.3.1.2.2. By Application
19.3.1.2.3. By Molecule Type
19.3.1.2.4. Route of administration
19.3.1.2.5. By Distribution Channel
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product 
19.4.3. By Application
19.4.4. By Molecule Type
19.4.5. Route of administration
19.4.6. By Distribution Channel
19.5. Country Level Analysis & Forecast
19.5.1. Australia Market
19.5.1.1. Introduction
19.5.1.2. Market Analysis and Forecast by Market Taxonomy
19.5.1.2.1. By Product 
19.5.1.2.2. By Application
19.5.1.2.3. By Molecule Type
19.5.1.2.4. Route of administration
19.5.1.2.5. By Distribution Channel
19.5.2. New Zealand Market
19.5.2.1. Introduction
19.5.2.2. Market Analysis and Forecast by Market Taxonomy
19.5.2.2.1. By Product 
19.5.2.2.2. By Application
19.5.2.2.3. By Molecule Type
19.5.2.2.4. Route of administration
19.5.2.2.5. By Distribution Channel
20. MEA Market Analysis 2014-2021 and Forecast 2022-2032
20.1. Introduction
20.2. Historical Market Size (US$ Bn)  and Trend Analysis By Market Taxonomy, 2014-2021
20.3. Current and Future Market Size (US$ Bn) Forecast By Market Taxonomy, 2022 - 2032
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. South Africa
20.3.1.3. Rest of MEA
20.3.1.3.1. By Product 
20.3.1.3.2. By Application
20.3.1.3.3. By Molecule Type
20.3.1.3.4. Route of administration
20.3.1.3.5. By Distribution Channel
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product 
20.4.3. By Distribution Channel
20.5. Country Level Analysis & Forecast
20.5.1. GCC Countries Global Market
20.5.1.1. Introduction
20.5.1.2. Market Analysis and Forecast by Market Taxonomy
20.5.1.2.1. By Product 
20.5.1.2.2. By Application
20.5.1.2.3. By Molecule Type
20.5.1.2.4. Route of administration
20.5.1.2.5. By Distribution Channel
20.5.2. South Africa Countries Market
20.5.2.1. Introduction
20.5.2.2. Market Analysis and Forecast by Market Taxonomy
20.5.2.2.1. By Product 
20.5.2.2.2. By Application
20.5.2.2.3. By Molecule Type
20.5.2.2.4. Route of administration
20.5.2.2.5. By Distribution Channel
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies (Global Injectable Drugs)
21.2. Market Concentration
21.3. Market Share Analysis of Top Players
21.4. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive 
22.3.1.1. Novartis
22.3.1.1.1. Overview
22.3.1.1.2. Product Portfolio
22.3.1.1.3. Recent Developments
22.3.1.1.4. Regional Footprint
22.3.1.1.5. Strategy Overview
22.3.1.1.6. SWOT Analysis
22.3.1.2. Pfizer Inc., 
22.3.1.2.1. Overview
22.3.1.2.2. Product Portfolio
22.3.1.2.3. Recent Developments
22.3.1.2.4. Regional Footprint
22.3.1.2.5. Strategy Overview
22.3.1.2.6. SWOT Analysis
22.3.1.3. Teva Pharmaceutical Industries Ltd. 
22.3.1.3.1. Overview
22.3.1.3.2. Product Portfolio
22.3.1.3.3. Recent Developments
22.3.1.3.4. Regional Footprint
22.3.1.3.5. Strategy Overview
22.3.1.3.6. SWOT Analysis
22.3.1.4. Sanofi S.A. 
22.3.1.4.1. Overview
22.3.1.4.2. Product Portfolio
22.3.1.4.3. Recent Developments
22.3.1.4.4. Regional Footprint
22.3.1.4.5. Strategy Overview
22.3.1.4.6. SWOT Analysis
22.3.1.5. Sun Pharmaceutical Industries Ltd. 
22.3.1.5.1. Overview
22.3.1.5.2. Product Portfolio
22.3.1.5.3. Recent Developments
22.3.1.5.4. Regional Footprint
22.3.1.5.5. Strategy Overview
22.3.1.5.6. SWOT Analysis
22.3.1.6. AstraZeneca Plc
22.3.1.6.1. Overview
22.3.1.6.2. Product Portfolio
22.3.1.6.3. Recent Developments
22.3.1.6.4. Regional Footprint
22.3.1.6.5. Strategy Overview
22.3.1.6.6. SWOT Analysis 
22.3.1.7. Merck & Co., Inc.
22.3.1.7.1. Overview
22.3.1.7.2. Product Portfolio
22.3.1.7.3. Recent Developments
22.3.1.7.4. Regional Footprint
22.3.1.7.5. Strategy Overview
22.3.1.7.6. SWOT Analysis 
22.3.1.8. Viatris + Mylan N.V
22.3.1.8.1. Overview
22.3.1.8.2. Product Portfolio
22.3.1.8.3. Recent Developments
22.3.1.8.4. Regional Footprint
22.3.1.8.5. Strategy Overview
22.3.1.8.6. SWOT Analysis
22.3.1.9. Cipla Inc. 
22.3.1.9.1. Overview
22.3.1.9.2. Product Portfolio
22.3.1.9.3. Recent Developments
22.3.1.9.4. Regional Footprint
22.3.1.9.5. Strategy Overview
22.3.1.9.6. SWOT Analysis
22.3.1.10. Dr. Reddy’s Laboratories Ltd. 
22.3.1.10.1. Overview
22.3.1.10.2. Product Portfolio
22.3.1.10.3. Recent Developments
22.3.1.10.4. Regional Footprint
22.3.1.10.5. Strategy Overview
22.3.1.10.6. SWOT Analysis
22.3.1.11. Samsung Biologics
22.3.1.11.1. Overview
22.3.1.11.2. Product Portfolio
22.3.1.11.3. Recent Developments
22.3.1.11.4. Regional Footprint
22.3.1.11.5. Strategy Overview
22.3.1.11.6. SWOT Analysis
22.3.1.12. Abbott Laboratories
22.3.1.12.1. Overview
22.3.1.12.2. Product Portfolio
22.3.1.12.3. Recent Developments
22.3.1.12.4. Regional Footprint
22.3.1.12.5. Strategy Overview
22.3.1.12.6. SWOT Analysis
22.3.1.13. Amgen Incorporated
22.3.1.13.1. Overview
22.3.1.13.2. Product Portfolio
22.3.1.13.3. Recent Developments
22.3.1.13.4. Regional Footprint
22.3.1.13.5. Strategy Overview
22.3.1.13.6. SWOT Analysis
22.3.1.14. Baxter International Incorporated
22.3.1.14.1. Overview
22.3.1.14.2. Product Portfolio
22.3.1.14.3. Recent Developments
22.3.1.14.4. Regional Footprint
22.3.1.14.5. Strategy Overview
22.3.1.14.6. SWOT Analysis
22.3.1.15. Becton, Dickinson and Company
22.3.1.15.1. Overview
22.3.1.15.2. Product Portfolio
22.3.1.15.3. Recent Developments
22.3.1.15.4. Regional Footprint
22.3.1.15.5. Strategy Overview
22.3.1.15.6. SWOT Analysis
22.3.1.16. Bristol-Myers Squibb Company
22.3.1.16.1. Overview
22.3.1.16.2. Product Portfolio
22.3.1.16.3. Recent Developments
22.3.1.16.4. Regional Footprint
22.3.1.16.5. Strategy Overview
22.3.1.16.6. SWOT Analysis
22.3.1.17. GlaxoSmithKline Plc
22.3.1.17.1. Overview
22.3.1.17.2. Product Portfolio
22.3.1.17.3. Recent Developments
22.3.1.17.4. Regional Footprint
22.3.1.17.5. Strategy Overview
22.3.1.17.6. SWOT Analysis
22.3.1.18. Roche Holding Limited.
22.3.1.18.1. Overview
22.3.1.18.2. Product Portfolio
22.3.1.18.3. Recent Developments
22.3.1.18.4. Regional Footprint
22.3.1.18.5. Strategy Overview
22.3.1.18.6. SWOT Analysis
23. Assumptions and Acronyms Used
24. Research Methodology

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us